Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021

Date: March 9, 2017
Pages: 191
Price:
US$ 7,150.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P788EB8DD70EN
Leaflet:

Download PDF Leaflet

Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021
“The pharmaceutical packaging market is projected to grow at a CAGR of 6.4% during forecast period, 2016 to 2021.”

The pharmaceutical packaging market is projected to reach USD 94.93 billion by 2021, at a CAGR of 6.4% during the forecast period, 2016 to 2021. The growth of the pharmaceutical packaging market can be attributed to increased demand from the emerging economies for improved healthcare services and increase in the aging population in developed economies, such as the U.S., the U.K., and Japan, among others. Other key factors driving the growth of the pharmaceutical packaging market are growing urbanization, increasing acceptance of oral administration of drugs, and technological advancements in the field of pharmaceutical packaging such as nanotechnology. However, factors such as, increase in overall packaging costs owing to dynamic regulatory measures, and stringent regulations set by various governing bodies to curb manufacturing of counterfeit medicines in several countries, are expected to restrain the growth of the pharmaceutical packaging market during the forecast period. Owing to relatively long shelf-life and stringent safety standards set for pharmaceutical packaging, the effort put in by pharmaceutical packaging suppliers and their raw material suppliers needs to be thorough and error-free. Moreover, it is required to be child and leakage proof. These factors are expected to restrain the growth of the pharmaceutical packaging market during the forecast period. In addition, counterfeit medicines are a major concern and an important challenge for the pharmaceutical industry.

“Among types, the pre-fillable syringes segment of the pharmaceutical packaging market is projected to grow at the highest CAGR during forecast period, 2016 to 2021.”

The pre-fillable syringes segment of the pharmaceutical packaging market is projected to grow at the highest CAGR from 2016 to 2021. Traditional vials and syringes are prone to dosing errors and as such, it is relatively difficult to achieve better patient compliance rates by using them. Pre-fillable syringes are gaining popularity across the globe, owing to increase in the number of people resorting to self-medication. These syringes are for one-time use and allow easy drug administration. Growing elderly population across the globe, who need regular treatment via dosing, is one of the key drivers for the growth of the pharmaceutical packaging market.

“Among veterinary vaccines, the livestock segment is projected to lead the pharmaceutical packaging market during the forecast period, 2016 to 2021.”

Among veterinary vaccines, the livestock segment is projected to lead the pharmaceutical packaging market during the forecast period. Livestock is mainly bred for food, such as meat and dairy products. Hence, prevention of diseases in livestock is a major concern to obtain healthy food products from these animals.

“The Asia-Pacific pharmaceutical packaging market is projected to grow at the highest CAGR during the forecast period, 2016 to 2021.”

Improvement in healthcare systems and increased access to healthcare services in the Asia-Pacific region could offer new opportunities to pharmaceutical packaging providers for growth in the region. The Asia-Pacific pharmaceutical packaging market is projected to grow at the highest CAGR during the forecast period, owing to increase in the number of initiatives taken by various governments to promote manufacturing of pharmaceuticals in the region and continuously aging population.

The market sizes estimated in this study have been validated through primary interviews conducted with various industry experts, globally. These primary sources have been divided into three categories:
  • By Company Type- Tier 1-40%, Tier 2-40%, and Tier 3-20%
  • By Designation- C Level-10%, Director Level-50%, and Others-40%
  • By Region- Asia-Pacific-30%, North America-20%, Europe-40%, South America-5%, and Middle East & Africa-5%
The report provides profiles of major market players, such as Amcor Ltd. (Australia), Schott AG (Germany), AptarGroup, Inc. (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), and Capsugel Inc. (U.S.), among others and competitive strategies adopted by them to strengthen their position in the market.

RESEARCH COVERAGE

In this report, the pharmaceutical packaging market has been segmented on the basis of type, veterinary vaccine, drug delivery, raw material, and region. The objective of the study is to define, describe, and forecast the pharmaceutical packaging market on the basis of various segmentations and to strategically analyze the market segments with respect to individual growth trends, future prospects, and contribution to the total market.

REASONS TO BUY THE REPORT

The report will help market leaders/new entrants in this market in the following ways:

1. This report segments the pharmaceutical packaging market comprehensively and provides the closest approximations for sizes of all market segments and subsegments across different verticals and regions.
2. This report will help stakeholders in obtaining improved understanding of their competitors and gain insights about their businesses. The competitive landscape section includes detailed information about investments, expansions, new product launches, partnerships, agreements, collaborations, and mergers & acquisitions undertaken by the key players in the pharmaceutical packaging market.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary research
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary research
    2.1.2.2 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
  2.2.2 TOP DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
  2.4.1 ASSUMPTION

3 EXECUTIVE SUMMARY

3.1 INTRODUCTION

4 PREMIUM INSIGHTS

4.1 SIGNIFICANT OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET
4.2 PHARMACEUTICAL PACKAGING MARKET: BY TYPE
4.3 PHARMACEUTICAL PACKAGING MARKET SHARE, BY REGION
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY TYPE, 2014–2021
4.5 PHARMACEUTICAL PACKAGING MARKET SHARE, BY RAW MATERIAL AND REGION
4.6 PHARMACEUTICAL PACKAGING MARKET, BY VETERINARY VACCINES, 2014–2021

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 Growing pharmaceutical industry in emerging economies
    5.3.1.2 Growing demand for drug delivery devices and blister packaging
    5.3.1.3 Technological advancements to contribute to growth of pharmaceutical packaging
      5.3.1.3.1 Nanotechnology
      5.3.1.3.2 Child resistant packaging
      5.3.1.3.3 Radio-frequency identification (RFID)
      5.3.1.3.4 Stora Enso Pharma DDSi wireless technology
      5.3.1.3.5 Combination of twist-off caps & foil seal closures
      5.3.1.3.6 Launch of PP random copolymer grades
      5.3.1.3.7 Eco-friendly and sustainable packaging
      5.3.1.3.8 Braille compliance
      5.3.1.3.9 Smart technologies: Latest pharmaceutical packaging innovations
    5.3.1.4 Rising health and environment awareness
  5.3.2 RESTRAINTS
    5.3.2.1 Increasing overall packaging costs owing to dynamic regulatory measures
    5.3.2.2 Stringent regulations set by various governing bodies
  5.3.3 OPPORTUNITIES
    5.3.3.1 Growth in global demand for primary pharmaceutical packaging
    5.3.3.2 Rapidly increasing 3PL and other services in emerging markets
  5.3.4 CHALLENGES
    5.3.4.1 Gaining competitiveness in new geographies
    5.3.4.2 Safeguarding against counterfeit products
    5.3.4.3 Issues in serving the emerging markets

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.3 PORTER’S FIVE FORCES ANALYSIS
  6.3.1 THREAT OF NEW ENTRANTS
  6.3.2 THREAT OF SUBSTITUTES
  6.3.3 BARGAINING POWER OF BUYERS
  6.3.4 BARGAINING POWER OF SUPPLIERS
  6.3.5 INTENSITY OF COMPETITIVE RIVALRY

7 PHARMACEUTICAL PACKAGING MARKET, BY TYPE

7.1 INTRODUCTION
7.2 PLASTIC BOTTLES
  7.2.1 STANDARD PLASTIC BOTTLES
  7.2.2 PLASTIC DISPENSING BOTTLES
  7.2.3 PLASTIC JARS
  7.2.4 PLASTIC CANS
7.3 BLISTER PACKS
  7.3.1 COMPARTMENT PACKS
  7.3.2 WALLET PACKS
7.4 LABELS & ACCESSORIES
7.5 CAPS & CLOSURES
7.6 MEDICAL SPECIALTY BAGS
7.7 PRE-FILLABLE SYRINGES
7.8 TEMPERATURE CONTROLLED VACCINES/MEDICINES PACKAGING
7.9 POUCHES & STRIP PACKS
7.10 AMPOULES
7.11 VIALS
7.12 PRE-FILLABLE INHALERS
  7.12.1 METERED DOSE INHALERS
  7.12.2 DRY POWDER INHALERS
7.13 MEDICATION TUBES
  7.13.1 COMPOSITE TUBES
  7.13.2 ALL-PLASTIC TUBES
  7.13.3 COLLAPSIBLE METAL TUBES
7.14 JARS & CANISTERS
7.15 CARTRIDGES
7.16 OTHERS

8 PHARMACEUTICAL PACKAGING MARKET FOR VETERINARY VACCINES

8.1 INTRODUCTION
8.2 LIVESTOCK VACCINES PACKAGING
8.3 PORCINE VACCINES PACKAGING
8.4 POULTRY VACCINES PACKAGING
8.5 CANINE VACCINES PACKAGING
8.6 FELINE VACCINES PACKAGING
8.7 EQUINE VACCINES PACKAGING
8.8 AQUACULTURE VACCINES PACKAGING

9 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE

9.1 INTRODUCTION
9.2 ORAL DRUG DELIVERY PACKAGING
9.3 PULMONARY DRUG DELIVERY PACKAGING
9.4 TRANSDERMAL DRUG DELIVERY PACKAGING
9.5 INJECTable PACKAGING
9.6 TOPICAL DRUG DELIVERY PACKAGING
9.7 NASAL DRUG DELIVERY PACKAGING
9.8 OCULAR DRUG DELIVERY PACKAGING
9.9 IV DRUGS DELIVERY PACKAGING
9.10 OTHER DRUGS DELIVERY PACKAGING

10 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL

10.1 INTRODUCTION
10.2 PLASTICS & POLYMERS
  10.2.1 HIGH-DENSITY POLYETHYLENE
  10.2.2 POLYESTER
  10.2.3 POLYPROPYLENE
  10.2.4 LOW-DENSITY POLYETHYLENE
  10.2.5 POLYVINYL CHLORIDE
10.3 PAPER & PAPERBOARD
10.4 GLASS
10.5 ALUMINUM FOIL
10.6 OTHERS

11 PHARMACEUTICAL PACKAGING MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH-AMERICA
  11.2.1 U.S.
  11.2.2 CANADA
  11.2.3 MEXICO
11.3 EUROPE
  11.3.1 GERMANY
  11.3.2 U.K.
  11.3.3 FRANCE
  11.3.4 SPAIN
  11.3.5 ITALY
  11.3.6 RUSSIA
  11.3.7 REST OF EUROPE
11.4 ASIA-PACIFIC
  11.4.1 CHINA
  11.4.2 JAPAN
  11.4.3 INDIA
  11.4.4 SOUTH KOREA
  11.4.5 AUSTRALIA & NEW ZEALAND
  11.4.6 REST OF ASIA-PACIFIC
11.5 MIDDLE EAST & AFRICA
  11.5.1 SAUDI ARABIA
  11.5.2 SOUTH AFRICA
  11.5.3 UAE
  11.5.4 REST OF MEA
11.6 SOUTH AMERICA
  11.6.1 BRAZIL
  11.6.2 ARGENTINA
  11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 MARKET RANKING OF KEY PLAYERS
  12.2.1 AMCOR LTD. (AUSTRALIA)
  12.2.2 BECTON, DICKINSON AND COMPANY (U.S.)
  12.2.3 APTARGROUP, INC.(U.S.)
  12.2.4 GERRESHEIMER AG (GERMANY)
  12.2.5 SCHOTT AG (GERMANY)
12.3 COMPETITIVE SITUATION AND TRENDS
  12.3.1 INVESTMENTS & EXPANSIONS
  12.3.2 NEW PRODUCT LAUNCHES
  12.3.3 MERGERS & ACQUISITIONS
  12.3.4 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS

13 COMPANY PROFILES

(Overview, Financial*, Products & Services, Strategy, and Developments)

13.1 AMCOR LTD.
13.2 BECTON, DICKINSON AND COMPANY
13.3 APTARGROUP, INC.
13.4 CAPSUGEL INC.
13.5 GERRESHEIMER AG
13.6 SCHOTT AG
13.7 OWENS-ILLINOIS, INC.
13.8 WEST PHARMACEUTICAL SERVICES, INC.
13.9 BERRY PLASTICS GROUP, INC.
13.10 WESTROCK COMPANY
13.11 SGD SA
13.12 OTHER MARKET PLAYERS

*Details might not be captured in case of unlisted companies

14 APPENDIX

14.1 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

LIST OF FIGURES

Figure 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
Figure 2 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION: TOP DOWN APPROACH
Figure 5 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
Figure 6 PRE-FILLABLE SYRINGES IS THE FASTEST-GROWING TYPE IN PHARMACEUTICAL PACKAGING MARKET DURING THE FORECAST PERIOD
Figure 7 LIVESTOCK VACCINE PACKAGING DOMINATED PHARMACEUTICAL PACKAGING MARKET
Figure 8 ORAL DRUG DELIVERY MODE DOMINATED PHARMACEUTICAL PACKAGING MARKET IN 2015
Figure 9 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
Figure 10 ATTRACTIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET BETWEEN 2016 AND 2021
Figure 11 PLASTIC BOTTLES TO ACCOUNT FOR THE LARGEST MARKET SHARE IN PHARMACEUTICAL PACKAGING MARKET, 2014–2021
Figure 12 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE IN 2015
Figure 13 ORAL DRUG DELIVERY MODE TO DOMINATE THE PHARMACEUTICAL PACKAGING MARKET
Figure 14 PLASTICS ACCOUNTED FOR THE LARGEST SHARE IN PHARMACEUTICAL PACKAGING MARKET, 2015
Figure 15 LIVESTOCK VACCINES TO DOMINATE THE PHARMACEUTICAL PACKAGING MARKET
Figure 16 PHARMACEUTICAL PACKAGING MARKET, BY REGION
Figure 17 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
Figure 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
Figure 19 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
Figure 20 PORTER’S FIVE FORCES ANALYSIS: PHARMACEUTICAL PACKAGING MARKET
Figure 21 PLASTIC BOTTLES IS THE LARGEST TYPE IN PHARMACEUTICAL PACKAGING MARKET
Figure 22 LIVESTOCK VACCINES TO BE THE LARGEST SEGMENT OF PHARMACEUTICAL PACKAGING MARKET FOR VETERINARY VACCINES, 2014–2021 (USD MILLION)
Figure 23 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
Figure 24 REGIONAL SNAPSHOT: ASIA-PACIFIC TO BE THE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET
Figure 25 NORTH AMERICAN MARKET SNAPSHOT: PLASTIC BOTTLES CAPTURED THE LARGEST MARKET SHARE IN 2015
Figure 26 EUROPE: THE THIRD-LARGEST PHARMACEUTICAL PACKAGING MARKET, 2014–2021 (USD BILLION )
Figure 27 ASIA-PACIFIC PHARMACEUTICAL PACKAGING MARKET SNAPSHOT: CHINA, JAPAN, AND INDIA ARE THE MOST LUCRATIVE MARKETS
Figure 28 INVESTMENTS & EXPANSIONS WAS THE KEY GROWTH STRATEGY ADOPTED BY LEADING COMPANIES, 2012–2016
Figure 29 MARKET SHARE: INVESTMENTS & EXPANSIONS IS THE KEY STRATEGY
Figure 30 AMCOR LTD.: COMPANY SNAPSHOT
Figure 31 AMCOR LTD.: SWOT ANALYSIS
Figure 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
Figure 33 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
Figure 34 APTARGROUP, INC.: COMPANY SNAPSHOT
Figure 35 APTARGROUP, INC.: SWOT ANALYSIS
Figure 36 GERRESHEIMER AG: COMPANY SNAPSHOT
Figure 37 GERRESHEIMER AG: SWOT ANALYSIS
Figure 38 SCHOTT AG: COMPANY SNAPSHOT
Figure 39 SCHOTT AG: SWOT ANALYSIS
Figure 40 OWENS-ILLINOIS, INC.: COMPANY SNAPSHOT
Figure 41 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
Figure 42 BERRY PLASTICS GROUP, INC.: COMPANY SNAPSHOT
Figure 43 WESTROCK COMPANY: COMPANY SNAPSHOT
Figure 44 SGD S.A.: COMPANY SNAPSHOT

The report “Pharmaceutical Packaging Market by Packaging Type, by Raw Material, by Drug Delivery Type by Region(North America, Europe, Asia-Pacific, RoW) - Forecasts to 2020” defines and segments the pharmaceutical packaging market with an analysis and forecast of value by type.

The market for pharmaceutical packaging, in terms of value, is projected to reach more than $80 Billion by 2020, witnessing a CAGR around 6.50% between 2015 and 2020.

The report also identifies the driving and restraining factors for the pharmaceutical packaging market with an analysis of drivers, restraints, opportunities, and strengths.

The market is segmented and the value has been projected on the basis of important regions, such as Asia-Pacific, North America, Europe, and Rest of the World (RoW). Further, the market is segmented and the volume and value are estimated based on various key raw materials and drug delivery types, such as oral, pulmonary, transdermal, injectable, topical, nasal, ocular, IV drugs, and other.

In developed countries, the growth of the injectable drug delivery technologies and solutions market is fast and contributes significantly to the pharmaceutical packaging market. This market is driven by factors such as innovations in injectable drug delivery devices, rising prevalence of diabetes in the U.S., the U.K., Germany, Italy, France, and Canada, improving patient safety & compliance and rise in partnerships, and collaborations and acquisitions among prominent players in this market.

In terms of value, North America followed by Europe dominated the pharmaceutical packaging market in 2014 and are projected to register a steady CAGR till 2020. High technological innovation and high environmental awareness along with moderate growth in the pharmaceutical market in the North American and European regions is leading to high consumption of pharmaceutical packaging in these regions. Due to rising spending capacity of consumers in the region, the pharmaceutical market is projected to witness a steady growth rate in Asia-Pacific and RoW. The pharmaceutical packaging market in Asia-Pacific is expected to witness highest growth rate between 2015 and 2020.

North America is the largest market for pharmaceutical packaging currently; however, by 2020, Asia-Pacific is expected to be the largest market. This growth is expected to be highest in the emerging economies of Brazil, Russia, India, and China, especially due to higher generics and contract manufacturing activities in these countries. Huge population and favorable demographics of these countries are key drivers behind this growth.

The material was prepared in July, 2015.

LIST OF TABLES

Table 1 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
Table 2 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE
Table 3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
Table 4 PHARMACEUTICAL PACKAGING MARKET, BY VETERINARY VACCINES
Table 5 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2014–2021 (USD BILLION)
Table 6 PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION)
Table 7 PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD BILLION)
Table 8 PLASTIC BOTTLES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 BLISTER PACKAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 10 LABELS & ACCESSORIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 CAPS & CLOSURES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 MEDICAL SPECIALTY BAGS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 PRE-FILLABLE SYRINGES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 TEMPERATURE CONTROLLED VACCINES/ MEDICINES PACKAGING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 POUCHES & STRIP PACKS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 AMPOULES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 VIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 PRE-FILLABLE INHALERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 MEDICATION TUBES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 20 JARS & CANISTERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 CARTRIDGES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 OTHERS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 23 PHARMACEUTICAL PACKAGING MARKET SIZE FOR VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 24 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY MODE, 2014–2021 (USD MILLION)
Table 25 BASIC PACKAGING MATERIAL USED IN PHARMACEUTICAL PACKAGING
Table 26 PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 ( USD MILLION)
Table 27 TYPE OF GLASS USED FOR DIFFERENT PACKAGING
Table 28 PHARMACEUTICAL PACKAGING MARKET SIZE, BY REGION, 2014–2021 (USD BILLION)
Table 29 PHARMACEUTICAL PACKAGING MARKET SIZE IN VETERINARY VACCINES, BY REGION, 2014–2021 (USD MILLION)
Table 30 PHARMACEUTICAL PACKAGING MARKET SIZE IN DRUG DELIVERY, BY REGION, 2014–2021 (USD BILLION)
Table 31 PHARMACEUTICAL PACKAGING RAW MATERIAL MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 32 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION )
Table 33 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD MILLION )
Table 34 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 35 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 36 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2014–2021 (USD MILLION)
Table 37 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 (USD MILLION)
Table 38 MACROECONOMIC FACTORS OF NORTH AMERICAN COUNTRIES
Table 39 U.S.: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 40 CANADA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 41 MEXICO: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 42 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION )
Table 43 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD MILLION )
Table 44 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 45 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 46 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2014–2021 (USD MILLION)
Table 47 EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 (USD MILLION)
Table 48 MACROECONOMIC INDICATORS OF KEY EUROPEAN COUNTRIES
Table 49 GERMANY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 50 U.K.: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 51 FRANCE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 52 SPAIN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 53 ITALY: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 54 RUSSIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 55 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 56 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD BILLION )
Table 57 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD BILLION )
Table 58 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 59 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 60 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2014–2021 (USD MILLION)
Table 61 ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 (USD MILLION)
Table 62 MACROECONOMIC FACTORS OF KEY ASIA-PACIFIC COUNTRIES
Table 63 CHINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 64 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 65 INDIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 66 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 67 JAPAN: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 68 REST OF ASIA-PACIFIC: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 69 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION )
Table 70 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD MILLION )
Table 71 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 72 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 73 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2014–2021 (USD MILLION)
Table 74 MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 (USD MILLION)
Table 75 MACROECONOMIC FACTORS OF KEY MIDDLE EAST & AFRICAN COUNTRIES
Table 76 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 78 UAE: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 79 REST OF MEA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 80 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION )
Table 81 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2014–2021 (USD MILLION )
Table 82 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 83 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY VETERINARY VACCINES, 2014–2021 (USD MILLION)
Table 84 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY DRUG DELIVERY, 2014–2021 (USD MILLION)
Table 85 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY RAW MATERIAL, 2014–2021 (USD MILLION)
Table 86 MACROECONOMIC FACTORS OF NORTH AMERICAN COUNTRIES
Table 87 BRAZIL: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 88 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION )
Table 89 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 90 MARKET RANKING
Table 91 INVESTMENTS & EXPANSIONS, 2012–2016
Table 92 NEW PRODUCT LAUNCHES, 2012–2016
Table 93 MERGERS & ACQUISITIONS, 2012–2016
Table 94 AGREEMENTS, JOINT VENTURES, AND PARTNERSHIPS, 2012–2016

Skip to top


Ask Your Question

Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: